摘要: In a survey carried out from 1985 through 1986, volunteer blood donors to The Greater New York Blood Program were tested for two surrogate markers nonA, non-B hepatitis—elevation of alanine aminotransferase level and presence antibody hepatitis B core antigen. Stored serum samples selected also recently C virus (anti-HCV). Anti-HCV was detected in 0.9% 1.4% higher black Hispanic than white donors. prevalence increased with increasing age the fourth decade life, but decreased thereafter, possibly reflecting disappearance detectable time. correlated both or absence These associations suggest that donor screening elevation antigen was, as expected, at least partially effective preventing transfusion-associated non-A, hepatitis. detection anti-HCV who have neither an nor suggests will further reduce risk ( JAMA . 1990;263:49-53)